Search

Search Constraints

You searched for: Author/Creator Stephens, Andrew W

Search Results

1. 18F‐PI‐2620 tau‐PET in corticobasal syndrome (ActiGliA cohort): Neuroimaging: Other neurodegenerative disorders. (7th December 2020)

2. Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study. Issue 4 (26th June 2014)

3. Baseline features of the AMYPAD Diagnostic and Patient Management Study (DPMS) participants: Neuroimaging / differential diagnosis. (7th December 2020)

4. Binding characteristics of [18F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. Issue 11 (November 2021)

5. CenTauRz: A standardized quantification of tau PET scans. (20th December 2022)

6. Converging evidence for a "gray‐zone" of amyloid burden and its relevance: The value of amyloid PET beyond dichotomization. (7th December 2020)

7. Current status and quantitative results of the AMYPAD prognostic and natural history study: Neuroimaging / Optimal neuroimaging measures for tracking disease progression. (7th December 2020)

8. Feasibility of short imaging protocols for [18F]PI‐2620 tau‐PET in progressive supranuclear palsy. (31st December 2021)

9. First results of the AMYPAD Prognostic and Natural History Study: amyloid‐PET Centiloid predicts cognitive functioning in a pre‐dementia population. (20th December 2022)

10. First results of the AMYPAD Prognostic and Natural History Study: amyloid‐PET centiloids predicts cognitive functioning in a pre‐dementia population. (20th December 2022)